Jacque J. Sokolov - Feb 22, 2024 Form 4 Insider Report for Lucid Diagnostics Inc. (LUCD)

Role
Director
Signature
/s/ Michael A. Gordon, by power of attorney
Stock symbol
LUCD
Transactions as of
Feb 22, 2024
Transactions value $
$0
Form type
4
Date filed
2/23/2024, 04:37 PM
Previous filing
Feb 2, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction LUCD Employee stock option (right to buy) Award $0 +150K $0.00 150K Feb 22, 2024 Common stock 150K $1.23 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 One third of the option vests on December 31, 2024; the balance vests in eight equal quarterly installments, starting March 31, 2025.